208 related articles for article (PubMed ID: 7019377)
1. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.
Loveland BE; Hogarth PM; Ceredig R; McKenzie IF
J Exp Med; 1981 May; 153(5):1044-57. PubMed ID: 7019377
[TBL] [Abstract][Full Text] [Related]
2. Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines.
Kim B; Rosenstein M; Weiland D; Eberlein TJ; Rosenberg SA
Transplantation; 1983 Nov; 36(5):525-32. PubMed ID: 6356516
[TBL] [Abstract][Full Text] [Related]
3. Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells.
Woodcock J; Wofsy D; Eriksson E; Scott JH; Seaman WE
Transplantation; 1986 Dec; 42(6):636-42. PubMed ID: 2947360
[TBL] [Abstract][Full Text] [Related]
4. Cells mediating graft rejection in the mouse. IV. The Ly-5, 6, and 8 effector cell phenotype.
Loveland BE; McKenzie IF
Transplantation; 1982 Apr; 33(4):411-3. PubMed ID: 6978559
[TBL] [Abstract][Full Text] [Related]
5. A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection.
LeFrancois L; Bevan MJ
J Exp Med; 1984 Jan; 159(1):57-67. PubMed ID: 6198428
[TBL] [Abstract][Full Text] [Related]
6. Immune mechanisms in organ allograft rejection. I. Delayed-type hypersensitivity and lymphocytotoxicity in heart graft rejection.
Lowry RP; Gurley KE; Forbes RD
Transplantation; 1983 Oct; 36(4):391-401. PubMed ID: 6353707
[TBL] [Abstract][Full Text] [Related]
7. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
Matoba AY; Peeler JS; Niederkorn JY
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
[TBL] [Abstract][Full Text] [Related]
9. The immunosuppressive effect of monoclonal anti-Lyt-1.1 antibodies in vivo.
Michaelides M; Hogarth PM; McKenzie IF
Eur J Immunol; 1981 Dec; 11(12):1005-12. PubMed ID: 6173235
[TBL] [Abstract][Full Text] [Related]
10. Cells mediating graft rejection in the mouse. III. Ly-1+ precursor T cells generate skin graft rejection.
Loveland BE; McKenzie IF
Transplantation; 1982 Apr; 33(4):407-10. PubMed ID: 7041367
[TBL] [Abstract][Full Text] [Related]
11. The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse.
Wheelahan J; McKenzie IF
Transplantation; 1987 Aug; 44(2):273-80. PubMed ID: 3114924
[TBL] [Abstract][Full Text] [Related]
12. Lyt phenotype of H-2b CTL effectors and precursors specific for the SV40 transplantation rejection antigen.
Flyer DC; Anderson RW; Tevethia SS
J Immunol; 1982 Dec; 129(6):2368-71. PubMed ID: 6292288
[TBL] [Abstract][Full Text] [Related]
13. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
Rosenberg AS; Mizuochi T; Sharrow SO; Singer A
J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237
[TBL] [Abstract][Full Text] [Related]
14. Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.
Cobbold S; Waldmann H
Transplantation; 1986 May; 41(5):634-9. PubMed ID: 3085299
[TBL] [Abstract][Full Text] [Related]
15. Delayed-type hypersensitivity and allograft rejection in the mouse: correlation of effector cell phenotype.
Loveland BE; McKenzie IF
Immunology; 1982 Jun; 46(2):313-20. PubMed ID: 7044959
[TBL] [Abstract][Full Text] [Related]
16. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
17. Cells mediating graft rejection in the mouse. II. The Ly phenotypes of cells producing tumor allograft rejection.
Loveland BE; McKenzie IF
Transplantation; 1982 Feb; 33(2):174-80. PubMed ID: 7036470
[TBL] [Abstract][Full Text] [Related]
18. The key role of Lyt-1+ cells in skin graft rejection in the mouse.
Loveland B; Ceredig R; Hogarth M; McKenzie I
Transplant Proc; 1981 Mar; 13(1 Pt 2):1079-81. PubMed ID: 7022917
[No Abstract] [Full Text] [Related]
19. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
Via CS; Sharrow SO; Shearer GM
J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
[TBL] [Abstract][Full Text] [Related]
20. Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection.
Nakayama E; Uenaka A
J Exp Med; 1985 Feb; 161(2):345-55. PubMed ID: 3871834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
